Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

ONEMED A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1%   Bankruptcy risk   0.8% 2.2% 2.2% 2.2% 0.5% 0.6% 4.6% 4.4%   Credit score (0-100)   93 67 66 64 99 97 46 47   Credit rating   AA BBB BBB BBB AAA AA BBB BBB   Credit limit (mDKK)   9.6 0.0 0.0 0.0 21.2 20.9 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1.0 Income statement (mDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   376 425 509 445 403 361 361 361   Gross profit   50.3 64.5 81.4 74.2 65.3 59.6 0.0 0.0   EBITDA   17.9 64.5 81.4 74.2 23.0 18.3 0.0 0.0   EBIT   17.7 64.5 81.4 74.2 18.5 13.2 0.0 0.0   Pre-tax profit (PTP)   20.1 23.5 36.1 24.6 15.4 4.6 0.0 0.0   Net earnings   15.7 23.5 36.1 24.6 11.6 3.6 0.0 0.0   Pre-tax profit without non-rec. items   20.1 64.5 81.4 74.2 15.4 4.6 0.0 0.0     See the entire income statement 1.0 Balance sheet (mDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.8 0.0 0.0 0.0 3.5 3.2 0.0 0.0   Shareholders equity total   97.7 121 157 182 193 197 196 196   Interest-bearing liabilities   17.2 0.0 0.0 0.0 149 123 0.0 0.0   Balance sheet total (assets)   168 193 226 238 404 396 196 196   Net Debt   17.2 0.0 0.0 0.0 149 123 -194 -194     See the entire balance sheet 1.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   376 425 509 445 403 361 361 361   Net sales growth   0.0% 13.1% 19.8% -12.7% -9.3% -10.4% 0.0% 0.0%   Gross profit   50.3 64.5 81.4 74.2 65.3 59.6 0.0 0.0   Gross profit growth   39.9% 28.2% 26.3% -8.9% -11.9% -8.7% -100.0% 0.0%   Employees   57 0 0 0 65 62 0 0   Employee growth %   0.0% -100.0% 0.0% 0.0% 0.0% -4.6% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   168 193 226 238 404 396 196 196   Balance sheet change%   7.8% 14.9% 16.8% 5.1% 70.0% -1.9% -50.6% 0.0%   Added value   17.9 64.5 81.4 74.2 18.5 18.3 0.0 0.0   Added value %   4.8% 15.2% 16.0% 16.7% 4.6% 5.1% 0.0% 0.0%   Investments   -0 -1 0 0 9 -5 -13 0   Net sales trend   0.0 1.0 2.0 -1.0 -2.0 -3.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   4.8% 15.2% 16.0% 16.7% 5.7% 5.1% 0.0% 0.0%   EBIT %   4.7% 15.2% 16.0% 16.7% 4.6% 3.7% 0.0% 0.0%   EBIT to gross profit (%)   35.1% 100.0% 100.0% 100.0% 28.3% 22.1% 0.0% 0.0%   Net Earnings %   4.2% 5.5% 7.1% 5.5% 2.9% 1.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   4.2% 5.5% 7.1% 5.5% 4.0% 2.4% 0.0% 0.0%   Pre tax profit less extraordinaries %   5.3% 15.2% 16.0% 16.7% 3.8% 1.3% 0.0% 0.0%   ROA %   12.4% 35.6% 38.8% 32.0% 5.9% 3.5% 0.0% 0.0%   ROI %   20.2% 41.8% 38.8% 32.0% 6.5% 4.2% 0.0% 0.0%   ROE %   17.4% 21.5% 25.9% 14.5% 6.2% 1.8% 0.0% 0.0%   1.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   57.9% 100.0% 100.0% 100.0% 47.9% 49.8% 100.0% 100.0%   Relative indebtedness %   18.8% 0.0% 0.0% 0.0% 51.9% 54.9% 0.0% 0.0%   Relative net indebtedness %   18.8% 0.0% 0.0% 0.0% 51.9% 54.9% -53.8% -53.8%   Net int. bear. debt to EBITDA, %   95.9% 0.0% 0.0% 0.0% 646.1% 672.9% 0.0% 0.0%   Gearing %   17.7% 0.0% 0.0% 0.0% 76.9% 62.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.2% 0.0% 0.0% 0.0% 4.8% 7.0% 0.0% 0.0%   1.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0   Current Ratio   2.4 0.0 0.0 0.0 0.7 0.6 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   1.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   59.9 0.0 0.0 0.0 33.6 36.0 0.0 0.0   Trade creditors turnover (days)   430.2 0.0 0.0 0.0 380.8 665.6 0.0 0.0   Current assets / Net sales %   44.6% 0.0% 0.0% 0.0% 33.3% 34.8% 53.8% 53.8%   Net working capital   96.8 0.0 0.0 0.0 -71.9 -69.5 0.0 0.0   Net working capital %   25.8% 0.0% 0.0% 0.0% -17.8% -19.2% 0.0% 0.0%   1.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   7 0 0 0 6 6 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0